Interestingly, HER2+-BC tumor cells lacking USP22 showed enrichment for gene signatures associated with stress-induced signaling pathways (e.g., hypoxia, p53 pathway) and apoptosis (Fig. 3B, C). The gene discussed is TP53; the disease is breast cancer.